MétaCan
Menu
← Back to cohort
Record W4397046351 · doi:10.1681/asn.20223311s1857a

Sixteen Weeks of High Amylose-Resistant Starch Supplementation Leads to a Reduction in p-Cresyl-Sulphate in Predialysis Patients

2022· article· en· W4397046351 on OpenAlexaff
Sam Headley, Donna J. Chapman, Karen Madsen, Elizabeth Evans, Allen E. Cornelius, Emily M. Miele, Kristyn Kirton, Joshua Loseke, Brian J. Martin, T. Alp İkizler, Michael J. Germain

Bibliographic record

VenueJournal of the American Society of Nephrology · 2022
Typearticle
Languageen
FieldMedicine
TopicFolate and B Vitamins Research
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsAmyloseMedicineInternal medicineStarchResistant starchReduction (mathematics)EndocrinologyChemistryFood scienceMathematics

Abstract

fetched live from OpenAlex

Background: Patients with chronic kidney disease (CKD) have high levels of systemic inflammation and oxidative stress. The current study was designed to determine the effect of 16 weeks of supplementation with high amylose resistant starch (HAM-RS2) on the microbiota and biomarkers indicative of inflammation, oxidative stress, and uremic toxins in stage 3-4 patients with CKD. Methods: This was a double-blind, placebo controlled, parallel arm, randomized controlled trial. Sixty-eight participants were randomized to one of two groups: HAM-RS2 & usual care (RS2) or placebo (cornstarch) & usual care (Con). RS2 was provided as Hi-Maize® 260 RS. For week 1, the dose of supplements was 15 grams/day. The dose was then increased to 33 grams/day for weeks 2-16. Participants attended two baseline (BL) sessions with follow up visits 8 (wk8) and 16 weeks (wk16) later. Fasting blood samples were collected at BL, wk8 and wk16. A stool sample was collected for analysis of microbial composition using 16s RNA sequencing at BL and wk16. The blood samples were analysed for interleukin 6, interleukin 10, tumor necrosis factor alpha, c reactive protein, monocyte chemoattractant protein-1, malondialdehyde, 8-isoprostanes F2a, indoxyl sulphate (IS), and p-cresyl sulphate (PCS). Results: Sixty-five patients completed the study (RS2 = 33, Con =32). RS2 led to a significant increase in the levels of butyrate producing bacteria. RS2 also led to a significant reduction in PCS (mg/dl): (BL,3.75 ± 2.88, wk8 3.34 ± 2.65, wk16 2.88 ± 1.78) χ2(2) = 8.74, p = .02, while the control group did not change (BL 3.01 ± 2.18, wk8 2.62 ± 1.71, wk16 3.13 ± 2.52) χ2(2) = 1.13, p = .57. Post hoc analysis indicated that the change from baseline to 16 weeks for PCS in the RS2 group was significant (p = .02). IS followed a similar pattern but did not reach statistical significance. In addition, RS2 did not lead to any significant changes in inflammatory or oxidative stress markers. Conclusions: Supplementation with RS2 led to a reduction in PCS in our sample of patients with CKD. Since high levels of PCS are associated with increased mortality and progression of CKD, our finding has important clinical implications. Funding: Commercial Support - Ingredion donated the resistant starch and the placebo that was used in this study

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.308
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicFolate and B Vitamins Research→French-language works237,207→